CompletedPhase 3NCT04328467

Pre-exposure Prophylaxis for SARS-Coronavirus-2

Studying Acute lung injury

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Minnesota
Principal Investigator
Radha Rajasingham, MD
University of Minnesota
Intervention
Hydroxychloroquine(drug)
Enrollment
1483 target
Eligibility
18 years · All sexes
Timeline
20202020

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04328467 on ClinicalTrials.gov

Other trials for Acute lung injury

Additional recruiting or active studies for the same condition.

See all trials for Acute lung injury

← Back to all trials